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The purpose of this study was to examine the effects of sarcolipin (SLN) on sarco(endo) plasmic
reticulum Ca2+-ATPase (SERCA pump) energetics in vivo and resting skeletal muscle metabolic rate.
Using SLN knockout (Sln/) mice we show that SLN ablation increases the transport stoichiometry
of SERCA pumps (Ca2+ uptake/Ca2+-ATPase activity) and decreases the relative contribution of SERCA
pumps to resting oxygen consumption (VO2) in soleus without affecting soleus or whole body VO2.
These data suggest that the lower energy requirements for Ca2+ cycling in resting skeletal muscle of
Sln/ mice do not impact signiﬁcantly either skeletal muscle or whole body metabolic rate.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Muscle contraction and relaxation are energy-dependent pro-
cesses that are regulated by Ca2+. In all muscle cells, the sarcoplas-
mic reticulum (SR) is the major organelle responsible for the
regulation of cytoplasmic free calcium ([Ca2+]f). Under basal condi-
tions in skeletal muscle, the sarco(endo)plasmic reticulum
Ca2+-ATPase (SERCA) pumps are responsible for maintaining a
>104-fold Ca2+ concentration gradient across the SR membrane
and for keeping [Ca2+]f below 100 nM [1]. In working muscle, SER-
CA pumps must rapidly pump large Ca2+ loads from the cytoplasm
into the lumen of the SR, thereby inducing muscle relaxation and
restoring SR Ca2+ stores that are utilized in the next contraction cy-
cle. SERCA pumps require energy in the form of ATP to pump Ca2+
from the cytosol into the SR. It is well established that the ATPase
activity of SERCA pumps contributes 30–40% of the energy cost
associated with muscle contraction (for review see [2]). Calorimet-
ric measurements in resting mouse soleus muscle indicate that 25–
45% of heat produced is related to SR Ca2+ pumping [3].
Under optimized states, SERCA pumps transport 2 mol of Ca2+
across the SR membrane by hydrolysis of 1 mol of ATP (see forward
reactions 1–6, Fig. 1) [4–6]. However, a number of experimental
procedures and conditions have been shown to lead to partial
uncoupling of Ca2+ transport from ATP hydrolysis through changesin the reaction cycle of the SERCA pump [5–13]. For example, pas-
sive Ca2+ efﬂux by the pump occurs when a high Ca2+ concentration
in the lumen of the SR promotes binding of Ca2+ to the E2 form of
the enzyme, leading to its conversion back to E1 (reactions 7–9,
Fig. 1) [5,7,11,13]. A high Ca2+ concentration in the lumen of the
SR can also increase the steady state level of E1Ca2P, which pro-
motes cleavage of Pi prior to Ca2+ translocation (i.e., uncoupled
ATPase activity) (reaction 10, Fig. 1) [5,8,11]. Finally, slippage is a
process that is deﬁned by the reaction whereby E1Ca2P releases
1–2 Ca2+ ions to the cytoplasmic side of the membrane rather than
to the lumenal side (reaction 11, Fig. 1) [6,11,13]. Although the
reactions of uncoupled ATP hydrolysis vary, the net result is the
same: ultimately most of the energy derived from ATP hydrolysis
is converted into heat [5,9,10,12–15].
Sarcolipin (SLN) is a 31 amino acid protein that regulates the
activity of SERCA pumps in muscle [16]. Reconstitution experi-
ments have shown that SLN uncouples ATP hydrolysis from Ca2+
transport by SERCA pumps [6] and increases the amount of heat re-
leased per mol of ATP hydrolyzed [13]. These results can be ex-
plained by SLN causing an increased rate of slippage of the
SERCA pump [6,13]. Even at a 50:1 M ratio of SLN:SERCA, there
was no signiﬁcant inhibition of ATP hydrolysis by SLN; however,
SLN decreased Ca2+ uptake into reconstituted vesicles at a molar
ratio of SLN:SERCA as low as 2:1 [6]. These results suggested that
SLN could have an important role in thermogenesis which we re-
cently conﬁrmed using SLN knockout (Sln/) mice [17]. Impor-
tantly, the effects of Sln ablation on the apparent Ca2+/ATP
Fig. 1. Schematic of the partial reactions in the catalytic and transport cycle of the SR Ca2+ pump showing coupled Ca2+ transport reactions (1–6 forward), passive leak
reactions (7–9), uncoupled ATPase activity (reaction 10) and slippage (reaction 11). (Figure redrawn from [5,13].)
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have yet to be determined. Therefore, in order to ﬁrmly establish
the mechanisms underlying the thermogenic function of SLN, here
wemeasured the ratio of SERCA pump Ca2+ transport/ATPase activ-
ity and both muscle and whole body oxygen consumption in Sln/
and wild type (WT) mice.
2. Materials and methods
2.1. Sln/ mice
The generation of Sln/ mice has been described previously
[18]. Animals were housed in an environmentally controlled room
with a standard 12:12 light/dark cycle and allowed access to food
and water ad libitum. Experiments were performed on littermate
Sln/ and WT males that were between the ages of 4–6 months.
All animal procedures were reviewed and approved by the Animal
Care Committee of the University of Waterloo and are consistent
with the guidelines established by the Canadian Council on Animal
Care.
2.2. SERCA Ca2+-ATPase activity and Ca2+ uptake
Ca2+-dependent SERCA ATPase activity was assessed in homog-
enates prepared fromWT and Sln/ soleus and extensor digitorum
longus (EDL) muscles over Ca2+ concentrations ranging from pCa
7.4 to 5.0 in the presence of a Ca2+ gradient (without ionophore
A23187) using a spectrophotometric plate reader assay which
has been described previously [19]. Using computer software
(GraphPad Prism™), SERCA activity–pCa curves were generated
by non-linear regression curve ﬁtting using an equation for a gen-
eral cooperative model for substrate activation. Ca2+ uptake activ-
ity was assessed in homogenates in the presence of a Ca2+ gradient
across the SR membrane (without the precipitating anion, oxalate)
using the ﬂuorescent dye Indo-1 and a spectroﬂuorometer
equipped with dual-emission monochromators [20]. To determine
the role of SLN on the Ca2+ transport efﬁciency of the SERCA
pumps, the Ca2+ uptake and SERCA ATPase activity rates were as-
sessed at pCa 6.9, 6.7 and 6.4 and the apparent coupling ratio(Ca2+ uptake/SERCA ATPase activity) was calculated. We use the
term apparent coupling ratio since we were not equipped to per-
form direct calorimetric measurements of the Ca2+/ATP ratio.
2.3. Western blot analysis
Western blotting was performed to assess the relative SLN pro-
tein expression inWTmouse soleus and atria. A polyclonal primary
antibody directed against SLN was generated in a rabbit host by
Lampire Biological Laboratories (PA, USA) using the C-terminus se-
quence LVRSYQY. Homogenate from mouse soleus and atria were
solubilized into 1 solubilizing buffer and proteins were electro-
phoretically separated using tricine-based SDS–PAGE and were
transferred onto 0.20 lm nitrocellulose membranes. Membranes
were incubated in blocking solution (TBST buffer: 20 mM Tris base,
137 mM NaCl, and 0.1% (v/v) Tween 20, pH 7.5, with 5% (w/v) non-
fat dry milk) for 1 h to block all non-speciﬁc binding sites. The
membranes were then incubated for 1 h in 5% milk-TBST contain-
ing the newly generated SLN antibody (1:100). The membranes
were then washed and incubated for 1 h in 5% milk-TBST contain-
ing goat anti-rabbit IgG (peroxidase conjugated) with a 1:2000
dilution. Membranes were washed again and antibody–antigen
complexes were visualized with a Chemi Genius2 Bio Imaging sys-
tem (Syngene, MD, USA) after addition of Supersignal West Fem-
toTM HRP substrate (Thermo Scientiﬁc, IL, USA).
2.4. Oxygen consumption in isolated intact soleus muscles
Resting oxygen consumption (VO2) of isolated intact soleus
muscles fromWT and Sln/mice was measured at 30 C in the ab-
sence (Rest) and presence of 10 mM MgCl2 using the TIOX tissue
bath system (Hugo Sachs Electronik–Harvard Apparatus, Ger-
many). The O2 partial pressure (PO2) of a bubble-free Ringer solu-
tion (in mM: 121 NaCl, 5 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 NaH2PO4, 24
NaHCO3, 5.5 glucose, and 0.1 EDTA, pH 7.3), which was preheated
to 30 C and aerated with 95% oxygen and 5% carbon dioxide, was
measured by a Clark O2 electrode (model 1302) connected to a
polarographic circuit, whose output voltage is directly proportional
to the PO2. The muscle length was adjusted to achieve optimal
E. Bombardier et al. / FEBS Letters 587 (2013) 1687–1692 1689length (Lo) for twitch force production and then the muscle was gi-
ven 10 min to equilibrate inside the chamber prior to initiating
data collection. PO2 measurements were recorded every 4 s during
each of three separate experimental trials designed to quantify
resting muscle VO2 and SERCA pump energetics. First, the decrease
in PO2 of the Ringer solution was recorded in the presence of a rest-
ing muscle at Lo for 30 min (rest). Second, the bath was emptied
and reﬁlled with oxygenated Ringer solution with an elevated con-
centration of MgCl2 (10 mM), and PO2 was recorded for 30 min.
Lastly, to determine muscle viability, the 10 mM MgCl2 solution
was washed out and the chamber was reﬁlled with fresh Ringer
solution and the PO2 was recorded for 30 min (washout). The dif-
ference in VO2 between MgCl2 and Rest trials was used to calculate
the relative contribution of SERCA activity to resting oxygen con-
sumption. The muscle VO2 was calculated by multiplying the mea-
sured drop in PO2 with time by the solubility of oxygen in Ringer
solution at 30 C and the chamber volume (12.7 mL). The solubility
of oxygen at 30 C was calculated to be 0.001203 M/atm. In reality,
the TIOX system is not completely closed to the atmosphere and
the electrode consumes oxygen to perform measurements result-
ing in loss of oxygen out of the solution even with no muscleFig. 2. Schematic summarizing the effects of Sln ablation on SERCA pump function meas
(B) without the Ca2+ ionophore A23187.mounted inside the chamber. Therefore, in order to account for
the oxygen loss, blank trials were done at the beginning and at
the end of daily data collection. A blank trial measures the rate
of oxygen loss from the empty chamber (i.e., no muscle). The aver-
age daily rate of oxygen loss is then subtracted from the oxygen
loss in the presence of the muscle to give the muscle VO2. The aver-
age rate of oxygen loss (lL/s) over the course of the experiment
was found to be 0.00803 ± 0.00055 with a coefﬁcient of variation
of 7.6%. Muscle VO2 is reported relative to muscle wet weight
(lL/g/s), and volumes are adjusted to standard temperature and
pressure (1.0 atm, 23 C).
2.5. Resting whole body metabolic parameters
Daily average whole body VO2, food consumption and total cage
activity (movement) were measured in WT and Sln/mice using a
Comprehensive Lab Animal Monitoring System (CLAMS) (Oxymax
series; Columbus Instruments, Columbus, OH). CLAMS studies be-
gan after 2 h of acclimation to the metabolic chamber and data
were collected at 26-min intervals over a 72-h period under a con-
sistent environmental temperature (22 C). O2 consumption wasured in soleus homogenates (A) with the Ca2+ ionophore A23187 (see Ref. [21]) and
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access to food and water.
2.6. Statistics
Analyses were performed using GraphPad Prism software. Data
are presented as mean ± S.E.M. A two-way ANOVA with repeated
measures was used to detect differences between WT and Sln/
mice for Ca2+-dependent SERCA ATPase activity. All other compar-
isons were made by Student’s t-test or ANOVA followed by a Tu-
key’s post hoc test. P values <0.05 were considered signiﬁcant.
3. Results and discussion
3.1. SLN ablation reduces slippage and increases the apparent coupling
ratio of SERCA pumps in soleus muscle
The generation of the Sln/ mouse model has been previously
described [18] and Sln/ mice have already been partially charac-
terized [17,18,21], but the effects of Sln ablation on the apparent
Ca2+/ATP coupling ratio of SERCA pumps and skeletal muscle
metabolism have not been explored in this model. Measurements
of Ca2+-ATPase activity in soleus homogenates were made with
and without the Ca2+ ionophore A23187. In the presence of the ion-
ophore, there is no Ca2+ gradient formed across the SR membrane
due to continual leakage of translocated Ca2+ ions. In the absence of
the ionophore, Ca2+ accumulates inside the SR vesicles and causes
back-inhibition of SERCA pumps, which is more relevant to the
physiological system found in skeletal muscle (see Fig. 2 and refer-
ence [7]). We have shown previously that Sln ablation increases the
apparent afﬁnity of SERCA pumps for Ca2+, as indicated by a signif-
icant decrease in KCa and a corresponding leftward shift in plots of
the Ca2+ dependence of Ca2+-ATPase activity, when assessed in the
presence of the ionophore [21]. In the absence of the ionophore,Fig. 3. SLN ablation decreases slippage, increases back-inhibition on SERCA pumps and i
ATPase activity was assessed in homogenates prepared fromWT and Sln/ soleus over C
(without Ca2+ ionophore A23187). Values are means ± S.E.M. (n = 5). (WT > Sln/, P < 0.0
oxalate) were measured in WT and Sln/ soleus homogenates at pCa 6.9 and the (D) app
are mean ± S.E.M. (n = 5), (⁄P < 0.05).SERCA activity was found to be signiﬁcantly lower in Sln/ com-
pared withWT soleus (Fig. 3A). This is consistent with the proposal
that SLN, by inducing slippage of SERCA pumps [6,13], reduces the
extent of back-inhibition of Ca2+ pump activity. Speciﬁcally, when
assessed at a pCa of 6.9, which is close to the physiological intra-
cellular free Ca2+ concentration in resting skeletal muscle [22],
Ca2+-ATPase activity (measured without ionophore) was 35%
lower in Sln/ compared with WT soleus (Fig. 3B), whereas Ca2+
uptake (measured in soleus homogenates without the precipitat-
ing anion, oxalate) was not different between WT and Sln/ mice
(Fig. 3C). Therefore, the apparent transport stoichiometry of SERCA
pumps (Ca2+ uptake/Ca2+-ATPase activity) is 35% lower in WT
than Sln/ soleus (Fig. 3D). At higher [Ca2+]f (i.e., pCa 6.7–6.4),
the apparent transport stoichiometry of SERCA pumps was also
25% higher (P < 0.05) in soleus muscles lacking SLN (data not
shown). Collectively, these results suggest that less energy is re-
quired by SERCA pumps to accomplish a given amount of SR Ca2+
uptake in soleus muscles from Sln/ compared with WT mice.
Previous Western blot analyses using an antibody directed
against the last 6 COOH terminus residues of SLN (–VRSYQY),
and conducted in M. Periasamy’s laboratory, have demonstrated
that SLN protein content in mouse soleus is 10 times lower than
mouse atria [21,23]. However, in another study, SLN protein could
not be detected in WT mouse soleus whereas it was readily detect-
able in mouse atria using a different antibody [24]. Here, we gen-
erated another antibody directed against the last 7 COOH
terminus residues of SLN (–LVRSYQY) in order to assess indepen-
dently, in our own laboratory, the relative SLN content in mouse
soleus. SLN protein could be detected in 25 lg of total muscle pro-
tein from WT soleus and as low as 1 lg of total muscle protein
from WT atria (Fig. 4). Compared with atria, SLN levels were
1000-fold lower in soleus. Despite loading 100 lg of total muscle
protein, SLN was not detected in soleus from Sln/ mice. The use
of a polyclonal primary antibody may explain the extent ofncreases the SERCA pump apparent coupling ratio. (A) Ca2+-dependent SERCA pump
a2+ concentrations ranging from pCa 7.4 to pCa 5.0 in the presence of a Ca2+ gradient
5). (B) SERCA pump activity (without Ca2+ ionophore) and (C) Ca2+ uptake (without
arent coupling ratio was calculated (Ca2+ uptake/SERCA pump ATPase activity). Data
Fig. 4. Representative Western blot image of SLN protein content in WT and Sln/ soleus and WT atria across a variety of total muscle protein loads. WC, Precision Plus
Western CTM standards visualized with Precision PlusTM StrepTactin–HRP Conjugate. The black arrow points to the predicted area of detection of SLN. The inset below
illustrates the strength of the SLN signal in wild-type soleus after adjusting brightness and contrast of the image ﬁle.
Fig. 5. The apparent coupling ratio of SERCA pumps in EDL is not altered by SLN
ablation. Ca2+-ATPase activity and Ca2+ uptake were assessed in EDL homogenates
in the presence of a Ca2+ gradient at pCa 6.9 and the apparent coupling ratio (Ca2+
uptake/Ca2+-ATPase activity) was calculated. Data are mean ± S.E.M. (n = 5).
Fig. 6. SLN ablation decreases both the absolute and relative energy consumption
by SERCA pumps in resting skeletal muscle. (A) Resting VO2 of isolated soleus
muscles from WT and Sln/ mice. Values are means ± S.E.M. (n = 19 or 21). (B)
Resting VO2 of isolated soleus muscles from WT and Sln/ mice during serial
30 min incubations in solutions containing 0.5 (rest and washout) or 10 mMMgCl2.
Values are means ± S.E.M. (n = 8 or 11). (MgCl2 < rest, washout; P < 0.001.) (C)
Percent reduction in resting VO2 of isolated soleus muscles fromWT and Sln/mice
induced by incubation in 10 mM MgCl2. Values are means ± S.E.M. (n = 8 or 11)
(⁄P < 0.05).
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that the loss of SLN resulted in a signiﬁcant increase in the appar-
ent coupling ratio of SERCA pumps in mouse soleus despite the rel-
ative low SLN content in that tissue as observed here and reported
elsewhere [24,25]. The mouse fast-twitch EDL muscle contains
even less SLN relative to soleus [21]. Therefore, we examined the
effects of SLN ablation on the apparent coupling ratio in EDL to
determine if the presence of SLN in that muscle is sufﬁcient to
uncouple Ca2+ transport by SERCA pumps. SLN ablation did not al-
ter the apparent coupling ratio of SERCA pumps in EDL (Fig. 5) indi-
cating that a molar ratio of SLN to SERCA at least higher than
normally found in EDL is required to affect SERCA transport
efﬁciency.
3.2. ATP consumption by SERCA pumps is signiﬁcantly reduced but
resting muscle and whole body VO2 is unchanged in Sln
/ mice
To determine whether higher apparent coupling ratios of SERCA
pumps in Sln/ soleus translated to lower muscle energy expendi-
ture, we measured oxygen consumption (VO2, lL/g wet weight/s)
of resting isolated soleus muscles from Sln/ and WT mice. Rest-
ing VO2 of isolated intact soleus muscles at 30 C was not signiﬁ-
cantly different (P = 0.11) between WT and Sln/ (Fig. 6A). In
order to quantify the speciﬁc contribution of Ca2+ cycling to resting
muscle VO2, we measured the change in VO2 of isolated soleus
muscles following the addition of 10 mM MgCl2, which blocks
Ca2+ release through the ryanodine receptor thereby indirectly
inhibiting SERCA pump activity [3]. Muscle VO2 in both WT and
Sln/ soleus was reduced following MgCl2 treatment (Fig. 6B),
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Fig. 7. Body weight, whole body VO2, food intake and cage activity (movement)
were not different between chow fed Sln/ andWTmice. (A) Body weight, (B) daily
(24 h average) whole body VO2, (C) food intake and (D) total cage activity
(movement) of WT and Sln/ mice that were maintained on a chow diet. Values
are means ± S.E.M. (n = 16).
1692 E. Bombardier et al. / FEBS Letters 587 (2013) 1687–1692but the relative decrease was signiﬁcantly greater in WT (Fig. 6C).
As a result, the relative contribution of SERCA pumps to resting VO2
in soleus is lower in Sln/ (35%) compared with WT (48%).
These results cannot be explained by differences in the content
of SERCA pumps (SERCA1a and SERCA2a) or other Ca2+ regulatory
proteins (e.g., calsequestrin) since we have shown previously that
the content of these proteins in soleus is unchanged in Sln/mice
[17,21]. We did not ﬁnd any evidence for compensatory increases
in Ca2+ cycling-independent VO2 in Sln/ soleus since muscle
VO2 following MgCl2 treatment was nearly identical in Sln/ and
WT soleus (Fig. 6B). There were also no differences in body weight
(Fig. 7A), daily whole body VO2 (Fig. 7B), daily food intake (Fig. 7C)
or daily cage activity (Fig. 7D) between WT and Sln/ mice. These
data suggest that the lower energy requirements for Ca2+ cycling in
resting skeletal muscle of Sln/ mice do not impact signiﬁcantly
either skeletal muscle or whole body metabolic rate and, therefore,
body weight, at least in chow fed mice.
In summary, using Sln/ mice we show that at a physiological
SLN:SERCA pump ratio, SLN uncouples ATP hydrolysis from SR Ca2+
uptake thereby increasing the amount of energy consumed by SER-
CA pumps in resting skeletal muscle. Although the lower energy
requirements for Ca2+ cycling in resting skeletal muscle of Sln/
mice do not impact signiﬁcantly either skeletal muscle or whole
body VO2 in chow fed mice, we have shown that SLN functions to
maintain core body temperature when mice are challenged to
acute cold and that loss of Sln predisposes mice to diet-induced
obesity [17]. Collectively, our studies strongly suggest that the pri-
mary physiological function of SLN in skeletal muscle is to regulate
thermogenesis by SERCA pumps.
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